Additionally, IL-6 (which is typically elevated in people with NAFLD) is overproduced during COVID-19 infection, resulting in a ‘cytokine storm’ that exacerbates the organism’s inflammation [44,45,46,47,48,49,50,51,52]. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatotic liver disease.